NAFLD
260
40
55
111
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
20 trials with published results (8%)
Research Maturity
111 completed trials (43% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.1%
8 terminated out of 260 trials
93.3%
+6.7% vs benchmark
8%
21 trials in Phase 3/4
18%
20 of 111 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 111 completed trials
Clinical Trials (260)
Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects
A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)
Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease
Lifestyle Modification in the Treatment of NAFLD.
Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease
Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)
NASH AMPK Exercise Dosing (AMPED) Trial
Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease
The Effects of 5-methyltetrahydrofolate Supplementation in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver Disease
GLP-1 RA on Liver OMICS in MASLD
Assessment of Fatty Liver With Thermo-acoustic Device
Reversal of Lipid-Induced Insulin Resistance
Short and Long Term Clinical and Patient-Reported Outcomes Associated With Intragastric Balloon Placement in Patients With Nonalcoholic Fatty Liver Disease
Effect of Obesity on Proton Pump Inhibitors
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
Bicalutamide Therapy in Young Women With NAFLD and PCOS